Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lennane

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical and Experimental Immunology|November 1, 1978
Complement, lymphocytotoxins and immune complexes in infectious mononucleosis: serial studies in uncomplicated casesJ A Charlesworth, J W Quin, G J Macdonald, et al.
The New Zealand Medical Journal|November 1, 1971
Two years' experience with cadaveric renal transplantationD Urquhart-Hay, R B Morrison, J McIlwaine, et al.
Klinische Wochenschrift|January 1, 1988
[Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]M Verstraete, M Bory, D Collen, et al.
Lancet (London, England)|April 13, 1985
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen ActivatorM Verstraete, R Bernard, M Bory, et al.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
The American Journal of Cardiology|August 1, 1987
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rateM Verstraete, A E Arnold, R W Brower, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical and Experimental Immunology|November 1, 1978
Complement, lymphocytotoxins and immune complexes in infectious mononucleosis: serial studies in uncomplicated casesJ A Charlesworth, J W Quin, G J Macdonald, et al.
The New Zealand Medical Journal|November 1, 1971
Two years' experience with cadaveric renal transplantationD Urquhart-Hay, R B Morrison, J McIlwaine, et al.
Klinische Wochenschrift|January 1, 1988
[Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]M Verstraete, M Bory, D Collen, et al.
Lancet (London, England)|April 13, 1985
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen ActivatorM Verstraete, R Bernard, M Bory, et al.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
The American Journal of Cardiology|August 1, 1987
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rateM Verstraete, A E Arnold, R W Brower, et al.
Pageof 3